Search results

Articles (6)

Journals (0)

1-6 of 6 results for idecabtagene vicleucel

Sort by:

Relevance

Select all

Sort by:

Relevance

Open access

Review article

First published 2021

The role of idecabtagene vicleucel in patients with heavily pretreated refractory multiple myeloma

Albert Oriol, Laura Abril, Anna Torrent [...]

Therapeutic Advances in Hematology

Retricted access

Review article

First published 2025-5

B-Cell Maturation Antigen-Directed Immunotherapies for the Treatment of Relapsed/Refractory Multiple Myeloma: A Review of the Literature and Implications for Clinical Practice

Matthew R. Peery, Hailey Hill, Amanda Sharps [...]

Annals of Pharmacotherapy

Open access

Research article

First published 2023-01

Cost-Effectiveness Analysis of CAR T-Cell Therapies vs Antibody Drug Conjugates for Patients with Advanced Multiple Myeloma

Kandice A. Kapinos, Ellen Hu, Jigar Trivedi [...]

Cancer Control

Open access

Review article

First published 2022

Toxicity management strategies for next-generation novel therapeutics in multiple myeloma

Mary Steinbach, Kelley Julian, Brian McClune [...]

Therapeutic Advances in Hematology

Retricted access

Review article

First published 2022-6

The emergence of b-cell maturation antigen (BCMA) targeting immunotherapy in multiple myeloma

James A. Davis, Abigail Shockley, Hamza Hashmi

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2025

Pharmacovigilance analysis of secondary primary malignancies and antibiotic interactions in CAR-T cell therapies

Yun Peng, Yuxuan Song, Jiaxing Lin [...]

Therapeutic Advances in Drug Safety